CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Ellenor Mittendorfer-Rutz - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Ellenor Mittendorfer-Rutz

OPENALEX: A5047541131↗ORCID: 0000-0001-5227-0721↗

Affiliations

Organizations

Karolinska Institutetauthorship · SE

Public evidence

4 connected articles

Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis.2026 · Europe PMC Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses2026 · PubMed Central Open Access Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study.2024 · Europe PMC Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 20162023 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.